Peer-Reviewed Study Placement Bodes Well For Artificial Heart Approval
This article was originally published in The Gray Sheet
Executive Summary
SynCardia's artificial heart study is a clinical "triumph" despite its lack of randomization and the relatively few patients who will need the implant, University of Utah cardiologist Dale Runland, MD, opines in a New England Journal of Medicine editorial
You may also be interested in...
SynCardia Artificial Heart Safety Should Be Confirmed Postmarket – Panel
A postmarket study of SynCardia's CardioWest Total Artificial Heart (TAH) is needed to confirm that its safety remains in the same range as shown in the firm's non-randomized PMA study, according to FDA's Circulatory System Devices Panel
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.